SKIP TO CONTENT
About Abbott
Contact
International | eng
Country Language

CARDIOVASCULAR

International | eng
Country Language

XIENCE Skypoint™ Stent 4.5 & 5.0 mm

Approved with left main indication¹

XIENCE Family

Treat a Wide Range of Large Vessel Lesions With XIENCE Skypoint™ Stents4

New Sizes

XIENCE Skypoint™ Stent offers a range of stent lengths from 12 mm to 33 mm to help treat a wide range of patients.4

12 mm
to
33 mm
Stent Sizes
Stent DiameterStent Length
12 mm15 mm18 mm23 mm28 mm33 mmMaximum Expansion
4.5 mm✓✓✓✓✓✓5.75 mm
5.0 mm✓✓✓✓✓✓5.75 mm

XIENCE Skypoint™ Stent Shows Accurate Stent Placement With Precise Stent and Marker Placement5

Precise Scaffolding

Accurate mid-marker placement enables precise scaffolding and reduces the likelihood of geographic miss to support optimal patient outcomes.5,6

Scaffolding comparison to Synergy and Resolute Onyx


XIENCE Skypoint™ Stent has Significantly Better Longitudinal Strength Than Other DES in Large Vessels7

Longitudinal strength supports better scaffolding in large coronary vessels. Less stent deformation delivers better patient outcomes.8
 

XIENCE Skypoint™ Stent Shows Significantly Less Stent Deformation Than
Synergy‡ and Resolute Onyx‡ – 5.0 mm Stents

Skypoint Stent Deformation
*Denotes significantly different when compared with XIENCE Skypoint™ Stent.

XIENCE™ Stent Shows Improvements in Measures of Quality of Life (QoL) in Patients With Left Main Lesions at 3 Years9

 

 

 

PCI With XIENCE™ Stent in patients with left main lesions showed sustained improvements in QoL out to 3 years9

SAQ - Quality of Life*
SAQ - Quality of Life

*Quality of life is a subscale of the Seattle Angina Questionnaire (SAQ). Scores for each subscale range from 0 to 100 with higher scores representing better health status. Comparison is made Vs baseline.
** Denotes statistically significant difference from baseline.

XIENCE™ Stent Shows Improvements in Measures of Quality of Life (QoL) in Patients With Left Main Lesions at 3 Years9

 

 

 

PCI With XIENCE™ Stent in patients with left main lesions showed sustained improvements in QoL out to 3 years9

SAQ - Quality of Life*
SAQ - Quality of Life

*Quality of life is a subscale of the Seattle Angina Questionnaire (SAQ). Scores for each subscale range from 0 to 100 with higher scores representing better health status. Comparison is made Vs baseline.
** Denotes statistically significant difference from baseline.

81% rate
Frequency of Angina-Free Incidences as Measured by SAQ – AF*
Angina Free Incidences

* Frequency of Angina is a subscale of the Seattle Angina Questionnaire (SAQ). Comparison is made vs baseline.
** Denotes statistically significant difference from baseline.

XIENCE™ Stent shows significantly lower definite stent thrombosis rates than Synergy‡ in patients with left main lesions at 2 years10
 

Definite Stent Thrombosis
ST Patients
81% rate
Frequency of Angina-Free Incidences as Measured by SAQ – AF*
Angina Free Incidences

* Frequency of Angina is a subscale of the Seattle Angina Questionnaire (SAQ). Comparison is made vs baseline.
** Denotes statistically significant difference from baseline.

XIENCE™ Stent shows significantly lower definite stent thrombosis rates than Synergy‡ in patients with left main lesions at 2 years10
 

Definite Stent Thrombosis
ST Patients


References

  1. XIENCE Skypoint™ Stent Instructions For Use (IFU). Refer to IFU for additional information.
  2. XIENCE Skypoint™ Stent – Instructions for Use (IFU). Refer to IFU for additional information. Zanchin, C. et al. J Am Coll Cardiol Intv. 2019;12(17):1665-1675. Serruys P, et al. N Engl J Med. 2010;363:136-146. Kufner S, et al. Circulation. 2019:139(3):325-333.
  3. Data on file at Abbott.
  4. XIENCE Skypoint™ Stent – Instructions for Use (IFU). Refer to IFU for additional information.
  5. Data on file at Abbott. XIENCE Skypoint™ Stent vs. Synergy‡ and Resolute Onyx‡ – 5.0 x 18 or 20 mm stents tested.
  6. Costa M, et al. Am J Cardiol. 2008;101:1704-1711; Sudhir, K., et al. ISRN Cardiology. 2013:1-8.
  7. Data on file at Abbott. XIENCE Skypoint™ Stent – 5.0 x 33 mm, n=5. Synergy‡ 5.0 x 32 mm, n=2. Resolute Onyx‡ – 5.0 x 33 mm , n=5. *Denotes significantly different when compared with XIENCE Skypoint™ Stent. Longitudinal stent compression test was done using 50 gf load.
  8. Shand J, et al. Interv Cardiol. 2012;4:325-335.
  9. Baron S, et al. J Am Coll Cardiol. 2017;70:3113-3122.
  10. Van Geuns R, et al. IDEAL-LM. TCT 2019


References

  1. XIENCE Skypoint™ Stent Instructions For Use (IFU). Refer to IFU for additional information.
  2. XIENCE Skypoint™ Stent – Instructions for Use (IFU). Refer to IFU for additional information. Zanchin, C. et al. J Am Coll Cardiol Intv. 2019;12(17):1665-1675. Serruys P, et al. N Engl J Med. 2010;363:136-146. Kufner S, et al. Circulation. 2019:139(3):325-333.
  3. Data on file at Abbott.
  4. XIENCE Skypoint™ Stent – Instructions for Use (IFU). Refer to IFU for additional information.
  5. Data on file at Abbott. XIENCE Skypoint™ Stent vs. Synergy‡ and Resolute Onyx‡ – 5.0 x 18 or 20 mm stents tested.
  6. Costa M, et al. Am J Cardiol. 2008;101:1704-1711; Sudhir, K., et al. ISRN Cardiology. 2013:1-8.
  7. Data on file at Abbott. XIENCE Skypoint™ Stent – 5.0 x 33 mm, n=5. Synergy‡ 5.0 x 32 mm, n=2. Resolute Onyx‡ – 5.0 x 33 mm , n=5. *Denotes significantly different when compared with XIENCE Skypoint™ Stent. Longitudinal stent compression test was done using 50 gf load.
  8. Shand J, et al. Interv Cardiol. 2012;4:325-335.
  9. Baron S, et al. J Am Coll Cardiol. 2017;70:3113-3122.
  10. Van Geuns R, et al. IDEAL-LM. TCT 2019

MAT-2208522 v1.0

POLICIES & ADVISORIES
HEALTHCARE PROFESSIONALS
PATIENTS & CAREGIVERS
Abbott logo

Information contained herein for distribution outside the U.S. only.

CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.

© 2024 Abbott. All Rights Reserved.

MAT-2001111 v7.0

Disclaimer

You are about to enter an Abbott country- or region-specific website. 

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions

Do you wish to continue and enter this website? 

YES

MAT-2305078 v1.0